Robert Ely is an accomplished executive director in process chemistry and CMC, currently serving at BridgeBio since 2021. Previously, Robert held key positions at Eidos, Medivation, and Achaogen, contributing significantly to small molecule drug development. Robert earned a Ph.D. in Organic Chemistry from Boston College and a Bachelor of Arts in Chemistry and Biochemistry from the University of Colorado at Boulder. Throughout their career, Robert has published extensively on advancements in synthetic methodologies, showcasing a strong background in medicinal chemistry.
This person is not in any teams
This person is not in any offices